SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-062914
Filing Date
2023-11-13
Accepted
2023-11-13 16:05:24
Documents
16
Period of Report
2023-11-13
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K aclx-20231113.htm   iXBRL 8-K 50398
2 EX-99.1 aclx-ex99_1.htm EX-99.1 32021
3 GRAPHIC img167846775_0.jpg GRAPHIC 28066
4 GRAPHIC img167846775_1.jpg GRAPHIC 46451
5 GRAPHIC img167846775_2.jpg GRAPHIC 180648
  Complete submission text file 0000950170-23-062914.txt   563621

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aclx-20231113.xsd EX-101.SCH 2454
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aclx-20231113_pre.xml EX-101.PRE 10667
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aclx-20231113_lab.xml EX-101.LAB 14572
10 EXTRACTED XBRL INSTANCE DOCUMENT aclx-20231113_htm.xml XML 5112
Mailing Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878
Business Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878 240-723-6641
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

IRS No.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41259 | Film No.: 231398559
SIC: 2836 Biological Products, (No Diagnostic Substances)